Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BNTC
#2989
Benitec Biopharma Inc. Common Stock
13.600
0
USD
+2.64%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.64%
Monthly Change
+14.67%
6 month change
-18.12%
Year Change
-18.12%
Previous Close
13.250
0
Open
13.600
0
Bid
Ask
Low
13.600
0
High
13.600
0
Volume
32
Markets
US Stock Market
Healthcare
BNTC
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Total assets
99.59 M
96.03 M
190.68 M
Total liabilities
2.3 M
2.43 M
3.32 M
Total equity
97.3 M
93.6 M
187.36 M
Total liabilities & shareholders' equities
99.59 M
96.03 M
190.68 M
Total debt
—
—
—
Net debt
—
—
—
News
Benitec BioPharma stock maintains Buy rating on positive trial data
Benitec reports interim results from gene therapy trial
Benitec BioPharma stock rating maintained on gene therapy data
Benitec to present BB-301 gene therapy study results in March
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
Citizens reiterates Market Outperform rating on Benitec BioPharma stock
Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target
Benitec’s gene therapy shows durable results in OPMD patients
Monday’s Insider Moves: Dolphin CEO’s Big Bet Amid Notable Sells
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?